{
  "name": "Consent Governance and Regulatory Parameters Across Healthcare and Research Settings",
  "description": "Comparative regulatory and clinical parameters governing implied consent, informed consent, documentation waivers, and emergency exceptions compiled from HHS 45 CFR 46, FDA 21 CFR 50, AMA Code of Medical Ethics, and federal common law standards.",
  "page": "https://casrai.org/compare/implied-consent-vs-informed-consent",
  "publisher": "CASRAI",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "dateModified": "2026-11-14T11:02:18Z",
  "temporalCoverage": "2024-2026",
  "spatialCoverage": "United States",
  "columns": [
    {
      "name": "Clinical or Research Context",
      "unit": "",
      "description": "Specific healthcare delivery or human subjects research environment"
    },
    {
      "name": "Governing Authority or Regulation",
      "unit": "",
      "description": "Primary statute, federal code, or professional ethical guidance"
    },
    {
      "name": "Default Consent Modality",
      "unit": "",
      "description": "Whether agreement is inferred through conduct or requires explicit communication"
    },
    {
      "name": "Documentation Mandate",
      "unit": "",
      "description": "Requirement for written signed form vs clinical progress note"
    },
    {
      "name": "Permissible Risk Level",
      "unit": "",
      "description": "Maximum risk classification under which the consent model is legally valid"
    },
    {
      "name": "Primary Mechanism for Exception or Waiver",
      "unit": "",
      "description": "Formal regulatory or common law provision permitting alteration"
    }
  ],
  "rows": [
    {
      "Clinical or Research Context": "Routine Outpatient Physical Examination",
      "Governing Authority or Regulation": "AMA Code of Medical Ethics Opinion 2.1.1; State Common Law",
      "Default Consent Modality": "Implied through non-verbal cooperation",
      "Documentation Mandate": "None required; documented in clinical chart",
      "Permissible Risk Level": "Minimal risk (non-invasive examination)",
      "Primary Mechanism for Exception or Waiver": "Explicit patient refusal or verbal objection"
    },
    {
      "Clinical or Research Context": "Acute Clinical Emergency (Incapacitated Patient)",
      "Governing Authority or Regulation": "Common Law Emergency Doctrine; AMA Opinion 2.1.1",
      "Default Consent Modality": "Implied under reasonable person standard",
      "Documentation Mandate": "Post-intervention emergency clinical documentation",
      "Permissible Risk Level": "Life-threatening or severe bodily harm risk",
      "Primary Mechanism for Exception or Waiver": "Prior documented Advance Directive or surrogate availability"
    },
    {
      "Clinical or Research Context": "Invasive Surgical and Interventional Procedures",
      "Governing Authority or Regulation": "State Medical Practice Acts; Hospital Licensing Bylaws",
      "Default Consent Modality": "Explicit informed consent (active dialogue)",
      "Documentation Mandate": "Signed and dated written consent form in medical record",
      "Permissible Risk Level": "Greater than minimal risk (all invasive interventions)",
      "Primary Mechanism for Exception or Waiver": "Emergency doctrine where delay threatens life"
    },
    {
      "Clinical or Research Context": "Anonymous Social and Behavioral Survey Research",
      "Governing Authority or Regulation": "HHS Common Rule (45 CFR 46.116 and 46.117)",
      "Default Consent Modality": "Explicit information sheet with implied participation",
      "Documentation Mandate": "Waived documentation under 45 CFR 46.117(c)(1)(ii)",
      "Permissible Risk Level": "Minimal risk only",
      "Primary Mechanism for Exception or Waiver": "IRB-approved waiver of documentation of consent"
    },
    {
      "Clinical or Research Context": "Interventional Clinical Drug and Device Trials",
      "Governing Authority or Regulation": "FDA 21 CFR 50.20, 50.25; Common Rule 45 CFR 46.116",
      "Default Consent Modality": "Explicit written or electronic informed consent",
      "Documentation Mandate": "IRB-approved signed consent form (written or eIC)",
      "Permissible Risk Level": "Minimal to significant risk (all interventional phases)",
      "Primary Mechanism for Exception or Waiver": "Emergency research exception under FDA 21 CFR 50.24 (EFIC)"
    },
    {
      "Clinical or Research Context": "Secondary Research on Identifiable Biospecimens",
      "Governing Authority or Regulation": "HHS Common Rule 45 CFR 46.116(d) and (f)",
      "Default Consent Modality": "Explicit broad consent or specific study consent",
      "Documentation Mandate": "Signed broad consent documentation or formal waiver",
      "Permissible Risk Level": "Minimal risk",
      "Primary Mechanism for Exception or Waiver": "Full IRB waiver of consent under 45 CFR 46.116(f)"
    }
  ],
  "sources": [
    {
      "title": "HHS Protection of Human Subjects (45 CFR Part 46)",
      "url": "https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-46",
      "accessed": "2026-11-14"
    },
    {
      "title": "FDA Protection of Human Subjects (21 CFR Part 50)",
      "url": "https://www.ecfr.gov/current/title-21/part-50",
      "accessed": "2026-11-14"
    },
    {
      "title": "AMA Code of Medical Ethics Opinion 2.1.1: Informed Consent",
      "url": "https://code-medical-ethics.ama-assn.org/ethics-opinions/informed-consent",
      "accessed": "2026-11-14"
    },
    {
      "title": "The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research",
      "url": "https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/index.html",
      "accessed": "2026-11-14"
    }
  ]
}